loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Magnesium Salicylate Tetrahydrate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Magnesium Salicylate Tetrahydrate

    APIs // Active Pharmaceutical Ingredients

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: 18917-95-8, Magnesium salicylate, Magnesium salicylate tetrahydrate, Backache caplets, Bayer select backache, 41728cy7ux
    Molecular Formula
    C14H18MgO10
    Molecular Weight
    370.59  g/mol
    InChI Key
    NBQBEWAYWAMLJJ-UHFFFAOYSA-L
    FDA UNII
    41728CY7UX
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    magnesium;2-carboxyphenolate;tetrahydrate
    2.1.2 InChI
    InChI=1S/2C7H6O3.Mg.4H2O/c2*8-6-4-2-1-3-5(6)7(9)10;;;;;/h2*1-4,8H,(H,9,10);;4*1H2/q;;+2;;;;/p-2
    2.1.3 InChI Key
    NBQBEWAYWAMLJJ-UHFFFAOYSA-L
    2.1.4 Canonical SMILES
    C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].O.O.O.O.[Mg+2]
    2.2 Other Identifiers
    2.2.1 UNII
    41728CY7UX
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Keygesic-10

    2. Magan

    3. Magnesium Salicylate

    4. Mobidin

    5. Momentum (magnesium Salicylate)

    2.3.2 Depositor-Supplied Synonyms

    1. 18917-95-8

    2. Magnesium Salicylate

    3. Magnesium Salicylate Tetrahydrate

    4. Backache Caplets

    5. Bayer Select Backache

    6. 41728cy7ux

    7. Magnesium Salicylate (1:2), Tetrahydrate

    8. 6150-94-3

    9. Magnesiumsalicylatetetrahydrate

    10. Chembl3989810

    11. Dtxsid601015599

    12. Magnesium Salicylate [inci]

    13. Magnesium Salicylate [vandf]

    14. Mfcd01766176

    15. Magnesium Salicylate [usp-rs]

    16. Magnesium Salicylate [who-dd]

    17. Magnesium Salt Of 2-hydroxybenzoic Acid

    18. Magnesium Salicylate [usp Monograph]

    19. Magnesium 2-hydroxybenzoate Hydrate (1:2:4)

    20. Magnesium Salicylate Tetrahydrate [mi]

    21. Q20817210

    22. Magnesium, Bis(2-(hydroxy-.kappa.o)benzoato-.kappa.o)-, Hydrate (1:4), (t-4)-

    2.4 Create Date
    2011-12-26
    3 Chemical and Physical Properties
    Molecular Weight 370.59 g/mol
    Molecular Formula C14H18MgO10
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count2
    Exact Mass370.0750385 g/mol
    Monoisotopic Mass370.0750385 g/mol
    Topological Polar Surface Area125 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity133
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count7
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Inflammatory Agents, Non-Steroidal

    Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

    Cyclooxygenase Inhibitors

    Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)

    4.2 FDA Pharmacological Classification
    4.2.1 Pharmacological Classes
    Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]; Central Nervous System Stimulant [EPC]
    Post Enquiry
    POST ENQUIRY